Results 1 to 10 of about 29,065 (252)

Gene therapy in an era of emerging treatment options for hemophilia B

Journal of Thrombosis and Haemostasis, 2015
Factor IX deficiency (hemophilia B) is less common than factor VIII deficiency (hemophilia A) and innovations in therapy for hemophilia B have generally lagged behind those for hemophilia A.
P E Monahan, P E Monahan
exaly   +3 more sources

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99

Journal of Thrombosis and Haemostasis, 2004
S C Darby, R J Spooner, P L F Giangrande
exaly  

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Blood, 2007
Paul L F Giangrande, Frank G H Hill, C R M HAY   +2 more
exaly  

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Blood, 2013
Jan Astermark, Astermark Jan, Donfield Sharyne M   +2 more
exaly  

Carriers of Hemophilia A and Hemophilia B

2018
openaire   +1 more source

Impact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B‐HERO‐S) study

European Journal of Haematology, 2017
Spencer Dunn, Skye Peltier, Neil Frick   +2 more
exaly  

Gene Therapy for Hemophilia

Molecular Therapy, 2017
Andrew M Davidoff
exaly  

Hemophilia A in the third millennium

Blood Reviews, 2013
Massimo Franchini, Pier Mannuccio Mannucci   +1 more
exaly  

Hemophilia A and B

2007
Lisa N. Boggio, Craig M. Kessler
openaire   +1 more source

Hemophilia A and B

Khine Swe Shan, Nyein Thaw Dar, Manuel Martinez-Rio   +2 more
openaire   +2 more sources